Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul T Thevenot

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Ochsner Journal|March 24, 2017
Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone RegulationKelley G Núñez, Janet Gonzalez-Rosario, Paul T Thevenot, et al.
Biomaterials|August 26, 2011
The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterialsPaul T Thevenot, David W Baker, Hong Weng, et al.
Particle and Fibre Toxicology|August 24, 2010
Nanomaterial cytotoxicity is composition, size, and cell type dependentSyed K Sohaebuddin, Paul T Thevenot, David Baker, et al.
Biomaterials|February 27, 2010
The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory responsePaul T Thevenot, Ashwin M Nair, Jinhui Shen, et al.
Frontiers in Oncology|July 5, 2022
Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed TherapyKelley G Núñez, Tyler Sandow, Meredith A Lakey, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2021
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survivalKelley G Núñez, Tyler Sandow, Daniel Fort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2023
Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization - Implications in treatment outcomesKelley G Núñez, Tyler Sandow, Juan Gimenez, et al.
Cancers|January 11, 2024
Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular CarcinomaJordin Stanneart, Kelley G Nunez, Tyler Sandow, et al.
Oncotarget|March 24, 2016
T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapyPatrick L Raber, Rosa A Sierra, Paul T Thevenot, et al.
Plos One|April 30, 2019
Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injuryKelley G Núñez, Anderson Frank, Janet Gonzalez-Rosario, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ochsner Journal|March 24, 2017
Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone RegulationKelley G Núñez, Janet Gonzalez-Rosario, Paul T Thevenot, et al.
Biomaterials|August 26, 2011
The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterialsPaul T Thevenot, David W Baker, Hong Weng, et al.
Particle and Fibre Toxicology|August 24, 2010
Nanomaterial cytotoxicity is composition, size, and cell type dependentSyed K Sohaebuddin, Paul T Thevenot, David Baker, et al.
Biomaterials|February 27, 2010
The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory responsePaul T Thevenot, Ashwin M Nair, Jinhui Shen, et al.
Frontiers in Oncology|July 5, 2022
Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed TherapyKelley G Núñez, Tyler Sandow, Meredith A Lakey, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2021
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survivalKelley G Núñez, Tyler Sandow, Daniel Fort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2023
Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization - Implications in treatment outcomesKelley G Núñez, Tyler Sandow, Juan Gimenez, et al.
Cancers|January 11, 2024
Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular CarcinomaJordin Stanneart, Kelley G Nunez, Tyler Sandow, et al.
Oncotarget|March 24, 2016
T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapyPatrick L Raber, Rosa A Sierra, Paul T Thevenot, et al.
Plos One|April 30, 2019
Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injuryKelley G Núñez, Anderson Frank, Janet Gonzalez-Rosario, et al.
Pageof 2